Diabetes Drugs to Carry Boxed Warnings of Heart Failure
After reviewing postmarketing adverse event reports, the FDA has determined that "black box warnings" (the FDA's strongest warning) should be provided on the labels of the entire thiazolidinedione class of antidiabetic drugs. These drugs are used in combination with diet and exercise to improve blood sugar control in adults with type 2 (non-insulin-dependent) diabetes.













